Ariad Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.11.18	Takeda: European Commission Approves ALUNBRIG For Patients With ALK+ NSCLC (RTTNews)
07.05.18	Statement from FDA Commissioner Scott Gottlieb, M.D., on the public health benefits from enactment of menu labeling (PR Newswire)
25.05.17	etventure Releases Study on the State of Digital Transformation (PR Newswire)
08.05.17	SOCs Grow Up: Results of a SANS Survey (PR Newswire)
06.02.17	ARIAD Pharma Reports Submission Of MAA For Brigatinib To EMA (RTTNews)
18.01.17	Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders (PR Newswire)
10.01.17	Gainers & Losers Of The Day: DFFN, ETRM, GNVC, EGRX, ADHD... (RTTNews)
09.01.17	Ariad Pharmaceuticals Holding On To Substantial Gain In Afternoon Trading (RTTNews)
09.01.17	Takeda To Buy ARIAD For $24.00/shr; Accretive To FY18 Underlying Core Earnings (RTTNews)
05.01.17	Biotech Stocks Under Review -- Novavax, Gilead Sciences, ARIAD Pharma, and Exelixis (PR Newswire)
21.12.16	Biotech Stocks Head Into 2017 With Clinical Developments That Could Lead to Growth and Added Value (PR Newswire)
06.12.16	New Collaborations and Licensing Activities for Biotech/Pharma Industries Pick Up Pace Heading into 2017 (PR Newswire)
29.11.16	ARIAD Pharma Announces FDA Full Approval And Label Update For Iclusig (RTTNews)
21.11.16	Biotech Stocks Under Review -- Novavax, Gilead Sciences, Ariad Pharma, and Exelixis (PR Newswire)
07.11.16	EARNINGS SUMMARY: Details of Ariad Pharmaceuticals Inc Q3 Earnings Report (RTTNews)
01.11.16	ARIA To Face FDA In April, OPXA's Woes Continue, Keep An Eye On OPHT (RTTNews)
26.10.16	ARIAD Pharma Reports Positive Preclinical Data Of Brigatinib - Quick Facts (RTTNews)
31.08.16	CEMP To Face FDA Panel, RIGL On A High, FDA Nod For Erelzi, KPTI Awaits STORM (RTTNews)
30.08.16	ARIAD Completes Rolling Submission Of NDA To FDA For ALK Inhibitor Brigatinib (RTTNews)
28.07.16	Ariad Pharmaceuticals Inc Q2 Profit Advances 117% (RTTNews)
17.06.16	ARIAD Announces Deal For Iclusig In Latin America, Middle East/North Africa (RTTNews)
17.06.16	ARIAD Initiates Submission Of NDA For Brigatinib To FDA Ahead Of Plan (RTTNews)
13.06.16	ARIAD Announces Data Of Ponatinib From Phase 2 Pace Clinical Trial (RTTNews)
06.06.16	ARIAD Pharma Updates Clinical Data On Brigatinib (RTTNews)
31.05.16	ARIAD Announces Initiation Of Phase 1/2 Clinical Trial Of AP32788 (RTTNews)
10.05.16	Ariad Pharma Says On Track To Complete Strategic Review In Q2 - Quick Facts (RTTNews)
10.05.16	EARNINGS SUMMARY: Details of Ariad Pharmaceuticals Inc Q1 Earnings Report (RTTNews)
09.05.16	Incyte To Acquire ARIAD's European Operations, In-license Iclusig In Europe (RTTNews)
30.03.16	FDA Panel Backs ACAD, AUPH Awaits Data In Q3, CTRV Abuzz (RTTNews)
11.03.16	ARIAD Pharma Appoints Manmeet Soni As CFO - Quick Facts (RTTNews)
23.02.16	Ariad Pharma Provides 2016 Product Revenue Outlook - Quick Facts (RTTNews)
23.02.16	EARNINGS SUMMARY: Details of Ariad Pharmaceuticals Inc Q4 Earnings Report (RTTNews)
11.01.16	ARIAD Pharma Elects Alexander Denner As Chairman - Quick Facts (RTTNews)
18.12.15	ARIAD Pharma Appoints Paris Panayiotopoulos As President And CEO - Quick Facts (RTTNews)
07.12.15	ARIAD Pharma Announces Initiation Of Randomized Phase 3 Trial Of Iclusig (RTTNews)
03.11.15	EARNINGS SUMMARY: Details of Ariad Pharmaceuticals Inc Q3 Earnings Report (RTTNews)
16.09.15	KOOL Tweaks Workforce, VNDA To Face FDA, XNPT Crashed For A Reason, TRIV Zooms (RTTNews)
02.09.15	Baxalta Reportedly Abandons Takeover Talks With Ariad Pharma (RTTNews)
05.08.15	EARNINGS SUMMARY: Details of Ariad Pharmaceuticals Inc Q2 Earnings Report (RTTNews)
10.06.15	ARIAD, Paladin Announce Commercial Distribution Deal For Iclusig In Canada (RTTNews)
31.05.15	ARIAD: Ponatinib Continues To Maintain Anti-leukemic Responses In Follow-up Data (RTTNews)
17.04.15	Ariad Pharma Updates Clinical Data On Brigatinib In Patients With ALK+ NSCLC (RTTNews)
06.04.15	ARIAD Pharma Reports Approval Of Iclusig In Canada - Quick Facts (RTTNews)
25.03.15	ARIAD: Court Dismisses Shareholder Class Action Lawsuit Related To Iclusig (RTTNews)
24.03.15	Ariad Pharma And Medison Pharma Say Iclusig Approved In Israel - Quick Facts (RTTNews)
19.02.15	Ariad Pharma Q4 Loss Narrows, Results Beat View - Quick Facts (RTTNews)
20.01.15	ARIAD: European Commission Endorses Iclusig's Approved Indications - Quick Facts (RTTNews)
13.01.15	ARIAD Pharma Aims To Achieve Sustained Profitability In 2018 - Quick Facts (RTTNews)
31.12.14	ARIA Widens Sales Turf, NRX Skips A Beat, NRDM Triples On Parkinson's Study (RTTNews)
30.12.14	Angelini To Commercialize ARIAD's Iclusig In Central And Eastern Europe (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Kuehne+Nagel Int	209.50	2.80 %	K V
CieFinRichemont	179.00	1.76 %	K V
Novartis	98.04	1.13 %	K V
Nestle	78.20	1.09 %	K V
ABB	50.60	1.04 %	K V
Part Grp Hldg	1’409.00	0.18 %	K V
Givaudan	3’829.00	0.03 %	K V
UBS Group	30.30	-0.03 %	K V
Swiss Re	141.70	-0.21 %	K V
Roche Hldg G	288.20	-0.83 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ariad Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten